BACKGROUND: Our aim was to study time-dependent modifications in the characteristics of renal transplants in Spain during the 1990s and risk factors associated with death-censored graft failure after the first year. METHODS: A total of 3,365 adult patients who underwent transplantation in 1990, 1994, and 1998 with a functioning graft after the first year were included. RESULTS: Ten-year patient and graft survival rates were 82% and 70%. Major modifications between 1990 and 1998 were increases in donor age (32 +/- 15 to 43 +/- 18 years, P<0.0001) and number of HLA mismatches (2.8 +/- 1.2 to 3.2 +/- 1.2, P<0.0001). Acute rejection decreased from 39% to 25% (P<0.0001), and the prevalence recipients with hepatitis C virus decreased from 29% to 10% (P<0.0001). The use of lipid-lowering agents during the first year increased from 6% to 41% (P<0.0001). Projected renal allograft half-life estimate was 15.4 (range, 14.1-16.8) years in 1990 and 17.7 (range, 14.0-21.4) in 1998 (P=0.007). Independent variables associated with graft survival were as follows: recipient age, last panel-reactive antibodies, acute rejection, hepatitis C virus antibodies in the recipient, triglycerides, serum creatinine and proteinuria at 3 months, and the increase of serum creatinine and proteinuria between the 3rd and 12th month. The use of statins during the first year was associated with a decreased risk for graft loss. CONCLUSION: Despite worsening of surrogate parameters of renal quality and poorer HLA matching, graft survival improved during the 1990s in Spain.
BACKGROUND: Our aim was to study time-dependent modifications in the characteristics of renal transplants in Spain during the 1990s and risk factors associated with death-censored graft failure after the first year. METHODS: A total of 3,365 adult patients who underwent transplantation in 1990, 1994, and 1998 with a functioning graft after the first year were included. RESULTS: Ten-year patient and graft survival rates were 82% and 70%. Major modifications between 1990 and 1998 were increases in donor age (32 +/- 15 to 43 +/- 18 years, P<0.0001) and number of HLA mismatches (2.8 +/- 1.2 to 3.2 +/- 1.2, P<0.0001). Acute rejection decreased from 39% to 25% (P<0.0001), and the prevalence recipients with hepatitis C virus decreased from 29% to 10% (P<0.0001). The use of lipid-lowering agents during the first year increased from 6% to 41% (P<0.0001). Projected renal allograft half-life estimate was 15.4 (range, 14.1-16.8) years in 1990 and 17.7 (range, 14.0-21.4) in 1998 (P=0.007). Independent variables associated with graft survival were as follows: recipient age, last panel-reactive antibodies, acute rejection, hepatitis C virus antibodies in the recipient, triglycerides, serum creatinine and proteinuria at 3 months, and the increase of serum creatinine and proteinuria between the 3rd and 12th month. The use of statins during the first year was associated with a decreased risk for graft loss. CONCLUSION: Despite worsening of surrogate parameters of renal quality and poorer HLA matching, graft survival improved during the 1990s in Spain.
Authors: Akinlolu O Ojo; José María Morales; Miguel González-Molina; Diane E Steffick; Fu L Luan; Robert M Merion; Tammy Ojo; Francesc Moreso; Manuel Arias; Josep María Campistol; Domingo Hernandez; Daniel Serón Journal: Nephrol Dial Transplant Date: 2012-07-02 Impact factor: 5.992
Authors: Daniel Seron; Marion Rabant; Jan Ulrich Becker; Candice Roufosse; Maria Irene Bellini; Georg A Böhmig; Klemens Budde; Fritz Diekmann; Denis Glotz; Luuk Hilbrands; Alexandre Loupy; Rainer Oberbauer; Liset Pengel; Stefan Schneeberger; Maarten Naesens Journal: Transpl Int Date: 2022-05-20 Impact factor: 3.842
Authors: Domingo Marrero; Domingo Hernandez; Lourdes Pérez Tamajón; Manuel Rivero; Ildefonso Lampreabe; Maria Dolores Checa; Jose Manuel Gonzalez-Posada Journal: NDT Plus Date: 2010-06
Authors: Jose Maria Morales; Roberto Marcén; Domingo del Castillo; Amado Andres; Miguel Gonzalez-Molina; Federico Oppenheimer; Daniel Serón; Salvador Gil-Vernet; Ildefonso Lampreave; Francisco Javier Gainza; Francisco Valdés; Mercedes Cabello; Fernando Anaya; Fernando Escuin; Manuel Arias; Luis Pallardó; Jesus Bustamante Journal: Nephrol Dial Transplant Date: 2012-12 Impact factor: 5.992
Authors: Jeonghwan Lee; Jang-Hee Cho; Jong Soo Lee; Dong-Won Ahn; Chan-Duck Kim; Curie Ahn; In Mok Jung; Duck Jong Han; Chun Soo Lim; Yon Su Kim; Young Hoon Kim; Jung Pyo Lee Journal: Medicine (Baltimore) Date: 2016-05 Impact factor: 1.889